- Home
- BCLI vs CISO Comparison
BCLI vs CISO Comparison
Compare BCLI & CISO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- CISO
- Stock Information
- Founded
- BCLI 2000
- CISO 2015
- Country
- BCLI United States
- CISO United States
- Employees
- BCLI N/A
- CISO N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- CISO Computer Software: Prepackaged Software
- Sector
- BCLI Health Care
- CISO Technology
- Exchange
- BCLI Nasdaq
- CISO Nasdaq
- Market Cap
- BCLI 6.4M
- CISO 5.9M
- IPO Year
- BCLI N/A
- CISO N/A
- Fundamental
- Price
- BCLI $0.92
- CISO $0.59
- Analyst Decision
- BCLI Strong Buy
- CISO
- Analyst Count
- BCLI 1
- CISO 0
- Target Price
- BCLI $30.00
- CISO N/A
- AVG Volume (30 Days)
- BCLI 366.6K
- CISO 8.0M
- Earning Date
- BCLI 05-13-2025
- CISO 05-19-2025
- Dividend Yield
- BCLI N/A
- CISO N/A
- EPS Growth
- BCLI N/A
- CISO N/A
- EPS
- BCLI N/A
- CISO N/A
- Revenue
- BCLI N/A
- CISO $30,750,695.00
- Revenue This Year
- BCLI N/A
- CISO N/A
- Revenue Next Year
- BCLI N/A
- CISO N/A
- P/E Ratio
- BCLI N/A
- CISO N/A
- Revenue Growth
- BCLI N/A
- CISO N/A
- 52 Week Low
- BCLI $0.72
- CISO $0.26
- 52 Week High
- BCLI $10.05
- CISO $3.84
- Technical
- Relative Strength Index (RSI)
- BCLI 35.85
- CISO 54.45
- Support Level
- BCLI $1.12
- CISO $0.44
- Resistance Level
- BCLI $0.82
- CISO $0.60
- Average True Range (ATR)
- BCLI 0.12
- CISO 0.07
- MACD
- BCLI 0.01
- CISO 0.04
- Stochastic Oscillator
- BCLI 36.36
- CISO 85.12
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.